{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:12:34Z","timestamp":1738645954628,"version":"3.35.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetes is a chronic disease, and hyperglycemia can increase the risk of diabetic complications and the need for more inpatient services. Therefore, the prevention and control of diabetes are important. This study aimed to identify the trajectories of metabolic control and its correlates in people with type 1 diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>This is a longitudinal study with 2020 type 1 diabetic individuals aged 18 to 59 years. The participants\u2019 glycosylated hemoglobin (HbA<jats:sub>1c<\/jats:sub>) was measured three times with a six-month interval between each measurement. The data were analyzed using group-based trajectory modeling. Multinomial logistic regression was used to determine the factors related to these groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results showed four trajectories of safe controlled (46.2%), moderate stable risk  (28.7%), moderate increasing risk (12.5%), and high decreasing risk trajectory (12.6%) (entropy\u2009=\u20090.70). The results of multinomial logistic regression showed dyslipidemia could increase the odds of being in the three risk trajectories. Education, physical inactivity, and poor psychological status could also increase the odds of being in the moderate stable and high decreasing trajectories. Moreover, sex, job, and BMI could increase the odds of being in the high decreasing risk group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Since there are different trajectories of metabolic control of diabetes, it is necessary for healthcare providers and health experts to plan behavioral interventions based on the location of individuals in different trajectories and the related significant risk factors. In this way, appropriate prevention, care, and treatment programs can be provided for the people in each group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-024-19098-1","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:51:04Z","timestamp":1738590664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic control and its associated factors in type 1 diabetic people: longitudinal trajectory modeling"],"prefix":"10.1186","volume":"25","author":[{"given":"Zahra","family":"Khosravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Taghipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monavar","family":"Afzalaghaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibollah","family":"Esmaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"19098_CR1","unstructured":"World Health Organization. Classification of diabetes mellitus-2019. 2019."},{"issue":"SUPPL1","key":"19098_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(SUPPL1):81\u201390.","journal-title":"Diabetes Care"},{"key":"19098_CR3","doi-asserted-by":"crossref","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Vol. 94, Diabetes Research and Clinical Practice. 2011. pp. 311\u201321.","DOI":"10.1016\/j.diabres.2011.10.029"},{"key":"19098_CR4","doi-asserted-by":"crossref","unstructured":"Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost AA, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: evidence from micro-simulation Markov model and bayesian meta-analysis. PLoS ONE. 2015;10(7).","DOI":"10.1371\/journal.pone.0132505"},{"issue":"10","key":"19098_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2337\/diacare.23.10.1516","volume":"23","author":"M Karvonen","year":"2000","unstructured":"Karvonen M, Maarit V-K, Elena M, Ingrid L, Ronald L, Jaakko T. Incidence of childhood type 1 diabetes. Diabetes Care. 2000;23(10):1516\u201326.","journal-title":"Diabetes Care"},{"issue":"2","key":"19098_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Heal Promot Perspect. 2020;10(2):98\u2013115.","journal-title":"Heal Promot Perspect"},{"issue":"2","key":"19098_CR7","first-page":"1","volume":"6","author":"D Zamanfar","year":"2018","unstructured":"Zamanfar D, Yazdani P, Aarabi M, Pournorooz H. The prevalence of type 1 diabetes in children of Mazandaran Province. Iran J Heal Sci. 2018;6(2):1\u201310.","journal-title":"Iran J Heal Sci"},{"issue":"4","key":"19098_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2337\/diacare.28.4.927","volume":"28","author":"GR Pishdad","year":"2005","unstructured":"Pishdad GR. Low incidence of type 1 diabetes in Iran. Diabetes Care. 2005;28(4):927\u20138.","journal-title":"Diabetes Care"},{"issue":"3","key":"19098_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2337\/dc16-1625","volume":"40","author":"A Schwandt","year":"2017","unstructured":"Schwandt A, Hermann JM, Rosenbauer J, Boettcher C, Dunstheimer D, Grulich-Henn J, et al. Longitudinal trajectories of metaboliccontrol from childhood to young adulthood in type 1 diabetes from a large German\/Austrian registry: a group-based modeling approach. Diabetes Care. 2017;40(3):309\u201316.","journal-title":"Diabetes Care"},{"issue":"2","key":"19098_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. LANCET Diabetes Endocrinol. 2018;6(2):122\u20139.","journal-title":"LANCET Diabetes Endocrinol"},{"issue":"125","key":"19098_CR11","first-page":"61","volume":"25","author":"MA Bigdeli","year":"2015","unstructured":"Bigdeli MA, Saeed S, Nazari H, Khodakarim S, Brodati H, Mafi H, et al. Factors associated with self-care behavior in patients with type II diabetes. J Maz Univ Med Sci. 2015;25(125):61\u201372.","journal-title":"J Maz Univ Med Sci"},{"issue":"3","key":"19098_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pcd.2019.07.002","volume":"14","author":"A Esteghamati","year":"2020","unstructured":"Esteghamati A, Ismail-Beigi F, Khaloo P, Moosaie F, Alemi H, Mansournia MA, et al. Determinants of glycemic control: phase 2 analysis from nationwide diabetes report of national program for prevention and control of diabetes (NPPCD-2018). Prim Care Diabetes. 2020;14(3):222\u201331.","journal-title":"Prim Care Diabetes"},{"key":"19098_CR13","doi-asserted-by":"crossref","unstructured":"Mohtasham-Amiri Z, Barzigar A, Kolamroudi HR, Hoseini S, Rezvani SM, Shakib RJ et al. Prevalence, awareness and control of diabetes in urban area of north of Iran, 2009. Int J Diabetes Dev Ctries. 2015.","DOI":"10.1007\/s13410-015-0305-4"},{"issue":"1","key":"19098_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1751-9004.2007.00054.x","volume":"2","author":"T Jung","year":"2008","unstructured":"Jung T, Wickrama KAS. An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass. 2008;2(1):302\u201317.","journal-title":"Soc Personal Psychol Compass"},{"issue":"1","key":"19098_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.20982\/tqmp.05.1.p011","volume":"5","author":"H Andruff","year":"2009","unstructured":"Andruff H, Carraro N, Thompson A, Ottawa PG, Louvet B. Latent class growth modelling: a tutorial. Tutor Quant Methods Psychol. 2009;5(1):11\u201324.","journal-title":"Tutor Quant Methods Psychol"},{"key":"19098_CR16","unstructured":"Burckhardt P, Nagin DS, Padman R. Multi-trajectory models of chronic kidney disease progression. In: AMIA Annu Symp Proc. 2016. pp. 1737\u20131746."},{"key":"19098_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","volume":"12","author":"H Lore","year":"2020","unstructured":"Lore H, Nguena Nguefack M, Gabrielle Pag\u00e9, Katz J, Manon Choini\u00e8re A, Vanasse, et al. Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. Clin Epidemiol. 2020;12:1205\u201322.","journal-title":"Clin Epidemiol"},{"issue":"12","key":"19098_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2337\/dc20-1531","volume":"43","author":"S Charleer","year":"2020","unstructured":"Charleer S, Block C, De, Nobels F, Radermecker RP, Lowyck I, Mullens A, et al. Sustained impact of real-time continuous glucose monitoring in adults with type 1 diabetes on insulin pump therapy: results after the 24-month RESCUE study. Diabetes Care. 2020;43(12):316\u201323.","journal-title":"Diabetes Care"},{"issue":"1","key":"19098_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"10","key":"19098_CR20","doi-asserted-by":"publisher","first-page":"107649","DOI":"10.1016\/j.jdiacomp.2020.107649","volume":"34","author":"SL Cichosz","year":"2020","unstructured":"Cichosz SL, Jensen MH, Hejlesen O. Associations between smoking, glucose metabolism and lipid levels: a cross-sectional study. J Diabetes Complications. 2020;34(10):107649.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"19098_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/1932296820922254","volume":"15","author":"MH -Jensen","year":"2021","unstructured":"-Jensen MH, Cichosz SL, Hirsch IB, Vestergaard P, Hejlesen O, Seto E. Smoking is Associated with increased risk of not achieving Glycemic Target, increased glycemic variability, and increased risk of hypoglycemia for people with type 1 diabetes. J Diabetes Sci Technol. 2021;15(4):827\u201332. https:\/\/doi.org\/10.1177\/1932296820922254.","journal-title":"J Diabetes Sci Technol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-19098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-19098-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-19098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:51:08Z","timestamp":1738590668000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-19098-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19098"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-19098-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this study used secondary data of people registered on electronic health records, it was not possible to ask people for consent, but the personal information and identity of all participants were kept confidential. Moreover, the Ethics Committee of Mashhad University of Medical Sciences approved the proposal for carrying out this research with the code of IR.MUMS.FHMPM.REC.1400.022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}